Both the Dow Jones Industrial Average and S&P 500 are now positive again for 2016 and closing in on their highs for the year. Although the markets have made their comeback, some stocks are still slowing that recovery and punishing their shareholders. Not to mention a potential Federal Reserve rate hike in June could take its toll on the markets as well.
We have picked out some companies that punished shareholders last week. These active stocks all issued or had news that pushed shares down. 24/7 Wall St. has included their recent trading history, as well as the 52-week trading range and the consensus analyst price target.
Shares of Tidewater Inc. (NYSE: TDW) dropped about 38% on Thursday to post a new 52-week low. This company reported a quarterly net loss and, worse, said it may not be in compliance with certain loan covenants. Tidewater reported its fiscal fourth-quarter as a net loss of $0.69 per share on $184.2 million in revenue. Consensus estimates had called for a net loss of $0.61 per share on $194 million in revenue.
Over the course of the week, the stock was down 32%. Shares of Tidewater fell to $4.24 on Friday’s close. The consensus price target is $7.21, and the 52-week range is $3.79 to $25.59.
Ionis Pharmaceuticals Inc. (NASDAQ: IONS) shares dropped severely after a less-than positive update on Thursday regarding its IONIS-TTR Rx program. The company is currently evaluating IONIS-TTRRx in an ongoing Phase 3 study, NEURO-TTR, in patients with transthyretin (TTR) familial amyloid polyneuropathy. Dr. Merrill Benson is also evaluating IONIS-TTRRx in an investigator-initiated Phase 2 open-label study in patients with TTR-related amyloid cardiomyopathy. Unfortunately the company decided not to initiate a Phase 3 outcome study, which was planned to evaluate IONIS-TTRRx in patients with TTR amyloid cardiomyopathy. As previously announced in April, the U.S. Food and Drug Administration (FDA) had placed this study on clinical hold as a result of safety findings in the ongoing NEURO-TTR study.
Over the past week, the stock was down 34%. Ionis shares ended the week at $22.00, within 52-week trading range of $19.59 to $71.50. The consensus price target is $52.56.
Palo Alto Networks
When Palo Alto Networks Inc. (NYSE: PANW) reported its fiscal third-quarter financial results after the markets closed on Thursday, it posted $0.42 in earnings per share (EPS) on $345.8 million in revenue. The Thomson Reuters consensus estimates had called for $0.42 in EPS on $339.48 million in revenue. In terms of guidance for the fiscal fourth quarter, the company expects EPS in the range of $0.48 to $0.50 and revenues in the range of $386 million to $390 million. The consensus estimates are $0.50 in EPS on $389.27 million in revenue for the current quarter.
The stock fell 8% over the course of the week and closed at $129.86 on Friday. The consensus price target is $195.70. The 52-week range is $111.09 to $200.55.
Following the announcement that Terex Corp.’s (NYSE: TEX) talks with Zoomlion were terminated, its shares tumbled in Friday’s session. At the same time, the company also announced that the sale of its Material Handling and Port Solutions business to Konecranes will proceed. The roughly $1.3 billion sale is subject to shareholder and regulatory approvals. It is expected to close in January 2017.
The stock dropped 15% from the peak level of the week. Shares closed Friday at $20.89, with a consensus price target of $25.52 and a 52-week range of $13.62 to $27.71.
After the markets closed on Wednesday, Pure Storage Inc. (NYSE: PSTG) reported its fiscal first-quarter financial results. The company said it had a net loss of $0.22 per share and $139.9 million in revenue. Consensus estimates had called for a net loss of $0.23 per share on $137 million in revenue. Guidance for the second quarter had revenues in the range of $153 million to $157 million, with a negative operating margin of 30% to 26%. The consensus estimate predicts a net loss of $0.24 per share on $157.77 million in revenue.
Last week, shares of Pure Storage were down 18%. The stock closed trading at $11.84 on Friday, with a consensus price target of $17.43 and a 52-week range of $11.05 to $20.60.